Pei-Ling Chen
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Molecular Biology top 2%
- Gut microbiota and health
- Melanoma and MAPK Pathways
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 11
- Cutaneous Melanoma Detection and Management 3
- Dermatology 10
- Cutaneous lymphoproliferative disorders research 8
- Cancer and Skin Lesions 2
- Co-authors
- Jennifer Ann Wargo (3 shared papers)Thomas R. Clandinin (4 shared papers)Tenghui Chen (1 shared paper)Lewis Z. Shi (1 shared paper)Jianfeng Chen (1 shared paper)Jianjun Gao (1 shared paper)Hao Zhao (1 shared paper)Jason Roszik (1 shared paper)
- Journals
- Journal of the National Comprehensive Cancer Network (5 papers)Cancer Discovery (4 papers)Neuron (2 papers)Clinical Cancer Research (2 papers)Modern Pathology (2 papers)
- Partner nations
- United StatesCanadaSweden
In The Last Decade
Pei-Ling Chen
38 papers receiving 8.9k citations
Pei-Ling Chen's Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 5k
- Molecular Biology 2.8k
- Immunology 699
- Cancer Research 398
- Biotechnology 148
Countries citing papers authored by Pei-Ling Chen
This map shows the geographic impact of Pei-Ling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei-Ling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei-Ling Chen more than expected).
Fields of papers citing papers by Pei-Ling Chen
This network shows the impact of papers produced by Pei-Ling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei-Ling Chen. The network helps show where Pei-Ling Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Pei-Ling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients Hit paper breakdown → | 2017 | 3860 |
| 2 | Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy Hit paper breakdown → | 2015 | 1299 |
| 3 | Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy Hit paper breakdown → | 2016 | 1085 |
| 4 | Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade Hit paper breakdown → | 2016 | 819 |
| 5 | Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance Hit paper breakdown → | 2017 | 708 |
| 6 | 2014 | 157 | |
| 7 | 2003 | 144 | |
| 8 | 2017 | 127 | |
| 9 | 2007 | 125 | |
| 10 | 2021 | 103 | |
| 11 | 2016 | 98 | |
| 12 | 2008 | 80 | |
| 13 | 2018 | 59 | |
| 14 | 2023 | 59 | |
| 15 | 2023 | 41 | |
| 16 | 2012 | 35 | |
| 17 | 2005 | 33 | |
| 18 | 2022 | 32 | |
| 19 | 2024 | 29 | |
| 20 | 2019 | 22 |
About Pei-Ling Chen
Pei-Ling Chen is a scholar working on Oncology, Dermatology, Cellular and Molecular Neuroscience, Immunology and Epidemiology, having authored 40 papers that have together received 9.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Cutaneous lymphoproliferative disorders research (8 papers), Axon Guidance and Neuronal Signaling (4 papers), Nonmelanoma Skin Cancer Studies (4 papers), Immunotherapy and Immune Responses (3 papers), Cutaneous Melanoma Detection and Management (3 papers), Melanoma and MAPK Pathways (3 papers) and Cancer and Skin Lesions (2 papers). The work is most often cited by research in Oncology (5k citations), Molecular Biology (2.8k citations), Immunology (699 citations), Cancer Research (398 citations) and Biotechnology (148 citations). Pei-Ling Chen has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Jennifer Ann Wargo, Thomas R. Clandinin, Tenghui Chen, Lewis Z. Shi, Jianfeng Chen, Jianjun Gao, Hao Zhao, Jason Roszik, James Patrick Allison and Chantale Bernatchez. Their work appears in journals such as Journal of the National Comprehensive Cancer Network, Cancer Discovery, Neuron, Clinical Cancer Research and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.